Related Experiment Videos

Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis

H Hardin-Pouzet1, M Krakowski, L Bourbonnière

  • 1Neuroimmunology Unit, Montreal Neurological Institute, Québec, Canada.

Glia
|May 1, 1997
PubMed

Insights

In experimental allergic encephalomyelitis (EAE), reactive astrocytes showed increased GFAP but decreased glutamate-metabolizing enzymes. This suggests impaired glutamate clearance by astrocytes may worsen EAE neuroinflammation and pathology.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Experimental Allergic Encephalomyelitis (EAE) is an animal model for multiple sclerosis.
  • Astrocytes play crucial roles in central nervous system homeostasis and disease.
  • Glutamate is a key excitatory neurotransmitter, but its excess can be neurotoxic.

Purpose of the Study:

  • To investigate the role of astrocytes in the pathology of EAE.
  • To examine the expression of glial fibrillary acidic protein (GFAP) and glutamate-metabolizing enzymes in EAE.

Main Methods:

  • EAE was induced in SJL/J mice via adoptive transfer of MBP-reactive T cells.
  • Semiquantitative Western blot and RT-PCR were used to analyze protein and mRNA expression.
  • Spinal cord tissues from EAE mice exhibiting grade 4 paralysis were analyzed.

Main Results:

  • GFAP expression was upregulated in the spinal cord, indicating reactive gliosis.
  • Expression of glutamine synthetase (GS) and glutamate dehydrogenase (GDH) was dramatically reduced.
  • These findings suggest a decreased astrocytic capacity for glutamate metabolism.

Conclusions:

  • Reactive astrocytes in EAE exhibit altered expression of key enzymes involved in glutamate homeostasis.
  • Reduced expression of GS and GDH may impair glutamate degradation, potentially contributing to neurotoxicity and EAE pathogenesis.
  • Targeting astrocytic glutamate metabolism could be a therapeutic strategy for EAE.

Related Concept Videos